Impact of brain-derived neurotrophic factor Val66Met polymorphism and response to escitalopram or paroxetine in obsessive–compulsive disorder

Ghina Harika-Germaneau, Nicolas Langbour, Sylvie Patri, Marcello Solinas, Armand Chatard, Bruno Millet, Farshad Hashemian, Marie-Christine Pérault-Pochat, Nematollah Jaafari, Claire Lafay-Chebassier

Open source

DOI: 10.1017/s1092852921000687
Published: 2021-07-27
Container: CNS Spectrums
Publisher: Cambridge University Press (CUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1017/s1092852921000687,
  title = {Impact of brain-derived neurotrophic factor Val66Met polymorphism and response to escitalopram or paroxetine in obsessive–compulsive disorder},
  author = {Ghina Harika-Germaneau and Nicolas Langbour and Sylvie Patri and Marcello Solinas and Armand Chatard and Bruno Millet and Farshad Hashemian and Marie-Christine Pérault-Pochat and Nematollah Jaafari and Claire Lafay-Chebassier},
  year = {2021},
  journal = {CNS Spectrums},
  doi = {10.1017/s1092852921000687},
  url = {https://doi.org/10.1017/s1092852921000687}
}

RIS

TY  - JOUR
TI  - Impact of brain-derived neurotrophic factor Val66Met polymorphism and response to escitalopram or paroxetine in obsessive–compulsive disorder
AU  - Ghina Harika-Germaneau
AU  - Nicolas Langbour
AU  - Sylvie Patri
AU  - Marcello Solinas
AU  - Armand Chatard
AU  - Bruno Millet
AU  - Farshad Hashemian
AU  - Marie-Christine Pérault-Pochat
AU  - Nematollah Jaafari
AU  - Claire Lafay-Chebassier
PY  - 2021
JO  - CNS Spectrums
DO  - 10.1017/s1092852921000687
UR  - https://doi.org/10.1017/s1092852921000687
ER  -

APA

Harika-Germaneau, G., Langbour, N., Patri, S., Solinas, M., Chatard, A., Millet, B., Hashemian, F., Pérault-Pochat, M., Jaafari, N., & Lafay-Chebassier, C. (2021). Impact of brain-derived neurotrophic factor Val66Met polymorphism and response to escitalopram or paroxetine in obsessive–compulsive disorder. CNS Spectrums. https://doi.org/10.1017/s1092852921000687

Source records

crossref · retrieved 2026-09-26T17:38:06.361Z